Mar 9, 2020   SOURCE: PR NewsWire

/DISREGARD RELEASE: Sysmex Inostics GmbH/

"We are advised by Sysmex Inostics GmbH that journalists and other readers should disregard the news release, Sysmex Inostics' Updated SafeSEQ Breast Cancer Panel Advances Novel Clinical Uses of ctDNA Through Quantitative Testing, issued on March 9, 2020 over PR Newswire, as a result of spreading too early."

SOURCE Sysmex Inostics GmbH